In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations'), Albert David has informed that it enclosed a summary of the proceedings of the 82nd Annual General Meeting (‘AGM’) of the Company held on 14th September, 2021 through Video Conferencing/Other Audio-Visual Means (‘VC/OAVM’), in compliance with the circulars issued by Ministry of Corporate Affair (‘MCA’) and Securities and Exchange Board of India (‘SEBI’). In connection with the above, the company has informed that Resolution Nos. 1 to 6 as stated in the Notice of the 82st AGM dated 17th June, 2021 were passed by the Shareholders by requisite majority.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: